aXichem AB (OSTO:AXIC A) Cyclically Adjusted Revenue per Share: kr0.23 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:AXIC A aXichem AB OSTO:AXIC A
65 GF Score
Price kr3.58
GF Value kr3.59
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is aXichem AB Cyclically Adjusted Revenue per Share?

aXichem AB OSTO:AXIC A +11.18% 65 Cyclically Adjusted Revenue per Share is kr0.23 as of Mar. 2026. GuruFocus rates OSTO:AXIC A with a GF Score™ of 65/100 and a GF Value™ of kr3.59 (Fairly Valued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

aXichem AB's adjusted revenue per share for the three months ended in Mar. 2026 was kr0.060. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr0.23 for the trailing ten years ended in Mar. 2026.

During the past 12 months, aXichem AB's average Cyclically Adjusted Revenue Growth Rate was 9.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 3.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of aXichem AB was 5.60% per year. The lowest was 3.10% per year. And the median was 4.35% per year.

As of today (2026-08-03), aXichem AB's current stock price is kr3.58. aXichem AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was kr0.23. aXichem AB's Cyclically Adjusted PS Ratio of today is 15.57.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of aXichem AB was 503.62. The lowest was 5.33. And the median was 32.11.


aXichem AB  (OSTO:AXIC A) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

aXichem AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3.58/0.23
=15.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of aXichem AB was 503.62. The lowest was 5.33. And the median was 32.11.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


aXichem AB Cyclically Adjusted Revenue per Share Related Terms


aXichem AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for aXichem AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

aXichem AB Cyclically Adjusted Revenue per Share Chart

aXichem AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.21 0.20 0.20 0.23

aXichem AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.22 0.22 0.23 0.23

OSTO:AXIC A vs LIN, SHW, ECL: Cyclically Adjusted Revenue per Share Comparison

For the Specialty Chemicals subindustry, aXichem AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


aXichem AB Cyclically Adjusted PS Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, aXichem AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where aXichem AB's Cyclically Adjusted PS Ratio falls into.


OSTO:AXIC A
65GF Score
aXichem AB OSTO:AXIC A
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

aXichem AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, aXichem AB's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.06/141.0300*141.0300
=0.060

Current CPI (Mar. 2026) = 141.0300.

aXichem AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.000 103.800 0.000
201609 0.000 104.200 0.000
201612 0.000 104.400 0.000
201703 0.000 105.000 0.000
201706 0.000 105.800 0.000
201709 0.000 105.900 0.000
201712 0.000 106.100 0.000
201803 0.007 107.300 0.009
201806 0.000 108.500 0.000
201809 0.014 109.500 0.018
201812 0.000 109.800 0.000
201903 0.000 110.400 0.000
201906 0.000 110.600 0.000
201909 0.000 111.100 0.000
201912 0.021 111.300 0.027
202003 0.067 111.200 0.085
202006 0.000 112.100 0.000
202009 0.006 112.900 0.007
202012 0.000 112.900 0.000
202103 0.003 114.600 0.004
202106 0.004 115.300 0.005
202109 0.194 117.500 0.233
202112 0.051 118.900 0.060
202203 0.029 119.800 0.034
202206 0.041 122.600 0.047
202209 0.015 125.600 0.017
202212 0.206 125.900 0.231
202303 0.033 127.600 0.036
202306 0.032 130.400 0.035
202309 0.013 129.800 0.014
202312 0.013 131.900 0.014
202403 0.037 132.600 0.039
202406 0.145 133.800 0.153
202409 0.012 133.700 0.013
202412 0.027 134.800 0.028
202503 0.057 136.100 0.059
202506 0.112 137.800 0.115
202509 0.077 138.500 0.078
202512 0.065 139.100 0.066
202603 0.060 141.030 0.060

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of kr0.23 mean?
aXichem AB (OSTO:AXIC A) has a Cyclically Adjusted Revenue per Share of kr0.23 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on aXichem AB and its competitors.
Is aXichem AB's Cyclically Adjusted Revenue per Share too high?
aXichem AB's current Cyclically Adjusted Revenue per Share is kr0.23. Overall, aXichem AB has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does aXichem AB's Cyclically Adjusted Revenue per Share compare to LIN and SHW?
aXichem AB's Cyclically Adjusted Revenue per Share of kr0.23 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Chemicals company?
A good Cyclically Adjusted Revenue per Share depends on the Chemicals industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on aXichem AB and its competitors. aXichem AB's current Cyclically Adjusted Revenue per Share is kr0.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aXichem AB stock overvalued right now?
Based on GuruFocus' analysis, aXichem AB (OSTO:AXIC A) is currently considered Fairly Valued. The stock's GF Value™ is kr3.59, compared to a current price of kr3.58 — trading 0.3% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is kr0.23. aXichem AB's overall GF Score™ is 65/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For aXichem AB (OSTO:AXIC A), the current Cyclically Adjusted Revenue per Share is kr0.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is aXichem AB (OSTO:AXIC A) Overvalued in 2026?

Based on GuruFocus' analysis, aXichem AB stock appears to be undervalued. The current stock price of kr3.58 is trading 0.3% below its estimated GF Value™ of kr3.59. GuruFocus considers aXichem AB to be Fairly Valued.

Key valuation signals for OSTO:AXIC A:

  • Cyclically Adjusted Revenue per Share: kr0.23
  • GF Value™: kr3.59 vs. price of kr3.58 (0.3% below fair value)
  • GF Score™: 65/100 with 1 warning sign

No single metric tells the full story. See the OSTO:AXIC A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


aXichem AB Business Description

Address Sodergatan 26, Malmo, NOR, 211 34
aXichem AB develops, patents, markets and sells natural analogue industrial chemicals, which are synthetically produced substances with similar and comparable properties to natural substances. The Company's business concept is to develop, patent, market and sell natural analogue industrial chemicals. Its commercial focus is on the proprietary patented product phenylcapsaicin, the Company's first product, which is marketed under the registered trademarks aXiphen as an additive in animal feed and aXivite as an ingredient in food supplements and as a bioenhancer. The Company's product portfolio comprises Phenylcapsaicin, aXiphen, aXiphen bio, and aXivite. The Company's focus is on establishing aXiphen as an additive in poultry feed and pig feed.
65GF Score

Get the complete analysis for OSTO:AXIC A

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.58
Price
kr3.59
GF Value